Carlyle Lining Up Debt for Medtronic Units Bid, Bloomberg Reports
--Carlyle Group is looking to arrange at least $2.5 billion in debt packages to support its potential acquisition of stakes in some of medical-device maker Medtronic's business units, Bloomberg reports, citing people with knowledge of the matter.
--The private-equity firm's talks with both Wall Street banks and private credit lenders are in the early stages, according to the report.
--Reuters last week reported that Carlyle is in talks to acquire a majority stake in two Medtronic medical-device businesses at a valuation of more than $7 billion.
Full story: https://www.bloomberg.com/news/articles/2023-10-03/carlyle-seeks-roughly-2-5-billion-debt-for-medtronic-units-bid?srnd=premium#xj4y7vzkg
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 03, 2023 12:57 ET (16:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Is the Era of Volatility-Suppressing Policies Possibly Over?
-
5 Undervalued Stocks That Crushed Earnings for Q1 2024
-
What Does Nvidia’s Stock Split Mean for Investors?
-
After Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Baidu Stock a Buy, a Sell, or Fairly Valued?
-
Why Stocks Are Hitting Record Highs—and What Could Send Them Back to Earth
-
5 Stocks to Buy While They’re Trading at Big Discounts
-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
Live Nation: Breakup Sought by Department of Justice Probably Wouldn’t Affect Fair Value Much
-
After Earnings, Is Applied Materials Stock a Buy, Sell, or Fairly Valued?
-
The Best Energy Stocks to Buy
-
Snowflake Earnings: Mixed News, But Signs of Stability
-
Nvidia Earnings: AI Demand Smashes Expectations Again
-
After Earnings, Is Walmart Stock a Buy, a Sell, or Fairly Valued?
-
Target Earnings: Margins Hold Up, but Top Line Constrained by Weak Discretionary Spending
-
Is Berkshire Hathaway’s Mystery Stock a Buy?